Annual Meeting CME & Disclosures

See important information about ACR Convergence 2024 continuing medical education (CME) and maintenance of certification (MOC) and disclosures.

Continuing Medical Education (CME)

ACCME Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

See the ACR's CME Mission Statement. For more information, download the AMA PRA Booklet.

AMA Designation Statement
The American College of Rheumatology designates this Other Activity (Blended Learning Encompassing Live and On Demand View) for a maximum of  209.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

CME credit must be claimed by November 13, 2025, at 11:59 PM ET.

Maintenance of Certification (MOC)

MOC Recognition Statement: American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 209.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.

After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.

MOC Recognition Statement: American Board of Pediatrics (ABP)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 209.50 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABP diplomates to the ABP diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABP Physician Portals. Please allow at least 48 hours for points to display in the portal.

MOC points must be claimed by November 13, 2025, at 11:59 PM ET.

Global Learning Objectives

Upon completion of this activity, participants should be able to:

• Assess their knowledge and competence in various rheumatic diseases and conditions.
• Support their skills in evaluating and diagnosing patients with rheumatic diseases.
• Discuss and collaborate on challenging cases with peers.
• Analyze emerging trends and technologies in rheumatology.
• Employ evidence-based approaches for managing rheumatic conditions.
• Identify new approaches and strategies for patient management.
• Interpret recent clinical trial and research findings.
• Apply new information from basic and clinical science to improve the care of people with rheumatologic illness.

Financial Relationships Disclosures

ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.

Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

1. Advisor or review panel member
2. Consultant
3. Employee
4. Officer or Board Member
5. Grant/research support
6. Speaker/honoraria includes speakers bureau, symposia, and expert witness
7. Independent contractor
8. Executive role and/or ownership interest
9. Royalties and/or patient beneficiary
10. Intellectual property/patents
11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
12. Private investigator
13. Expert witness
14. Equity interest
15. Other: specify details

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

CME Disclosures
Planning Committee Disclosures

Faculty Disclosures

Global Financial Relationships Disclosures

*All of the relevant financial relationships listed for these individuals have been mitigated.

Non-CME Disclosures
Abstract Reviewer Disclosures

Abstract Moderator Disclosures

Poster Tour Guide Disclosures

Abstract Study Sponsor Statements

Corporate Support

The ACR thanks the following organizations for their support of these ACR Convergence 2024 Education Tracks:

Diversity, Equity, and Inclusion
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Lilly USA, LLC

Lupus
Aurinia Pharmaceuticals Inc.
Genentech, Inc.
UCB, Inc.

Instructions to Claim CME/MOC Credit

MOC Notice

There is a change to the process to claim MOC credit for ACR Convergence 2024.

After you enter a reflective statement, you will be directed to an ACR Convergence 2024 post-test. To claim MOC, learners must pass the post-test with a score of 70% or more. You can take the test as many times as needed.

There are no changes to the process to claim CME for ACR Convergence 2024.

How to Claim Credit

Credit claiming is available after the activity starts.

The deadline to claim CME credit and MOC points for ACR Convergence 2024 is November 13, 2025, at 11:59 PM ET.

1. Log in to your My Credit page.
2. Locate ACR Convergence 2024 and click Claim Credit; enter the amount of credit commensurate with your participation
3. After claiming CME, you will be asked if you wish to claim ABIM MOC and/or ABP MOC. If you select Yes, you will be prompted to complete the following:
   • Select board(s) and enter or confirm your ABIM and/or ABP number and date of birth
   • Enter a reflective statement
   • Pass a post-test with a score of 70% or more (you can take the test as many times as needed – see instructions to return to the post-test below*)

*How to Return to MOC Post-Test
If you are not able to complete the MOC post-test and need to return to it later, follow the steps below. Note: your CME credit will be claimed if you don’t finish the MOC post-test.

1. Go to learn.rheumatology.org and log in
2. On the main menu, below My Education click My Learning
3. Scroll down to the Meetings section and click ACR Convergence 2024
4. Scroll down to the Post-Test section and click the link to the test